Skip to content

Clinical trials

Phase 2 Dermatitis, Atopic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 2 Country / region: United States Clear all

192 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20063
20071
20084
20096
20103
20124
20137
20143
201510
201612
20179
201817
201917
202012
202119
202212
202313
202413
202517
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed126
Terminated28
Recruiting16
Active, not recruiting14
Withdrawn4
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer8
Galderma R&D6
Janssen Research & Development, LLC6
Aclaris Therapeutics, Inc.5
Regeneron Pharmaceuticals5
Sanofi5
AbbVie4
Eli Lilly and Company4
GlaxoSmithKline4
Hoffmann-La Roche4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic192
Eczema66
Dermatitis21
Pruritus20
Skin Diseases13
Immune System Diseases7
Skin Diseases, Eczematous4
Food Hypersensitivity3
Lymphoma, Follicular3
Psoriasis3

Trials

Showing 1 to 25 of 192. Each trial links to its page on Pharma Observatory.

92 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.